Health Care

May 1, 2014

Expensive hepatitis C drug presents Medicaid payment quandary for SC

The challenge facing SC Medicaid program managers is how to balance Sovaldi’s up-front cost ($84,000) while also considering the health of hepatitis C patients. Criteria for payment to be released in the next few weeks.

Related content

Comments

Editor's Choice Videos